Dr. Robert Cameron | Los Angeles, California

Dr. Robert Cameron is a Mesothelioma Cancer Doctor at UCLA Medical Center, located in Los Angeles, California.

Mesothelioma Doctor Information

Dr. Robert Cameron - Los Angeles, California
Dr. Cameron is Assistant Professor of Surgery and the Director of Thoracic Oncology at UCLA Medical Center. He specializes in treating mesothelioma patients.

Department of Surgery
UCLA School of Medicine Center for the Health Sciences
P.O. Box 951741
Los Angeles, California 90095-1741
Phone: (310) 206-8232
Fax:(310) 794-7335
Email: rcameron@surgery.medsch.ucla.edu

Academic Title:
Assistant Professor Cardiothoracic Surgery and Surgical Oncology Director, Thoracic Oncology Department of Surgery UCLA School of Medicine Chief, General Thoracic Surgery Wadsworth Veterans Administration Hospital

Academic Appointments
Assistant Professor of Surgery
Institution: University of California, Los Angeles
Location: Los Angeles, California
Dates: March, 1997-present
Title: Chief, Thoracic Oncology
Hospitals: UCLA Medical Center

Medical Education:
Institution: University of California, Los Angeles
Location: Los Angeles, California
Degree: M.D. June, 1994

Undergraduate Education:
Institution: Stanford University
Location: Stanford, California
Attendance: September, 1976-June, 1980
G.P.A.: 3.90

Degree:
Bachelor of Arts and Science (B.A.S.) in medieval studies and biology Training

Cardiothoracic Surgery Institution:
New York Hospital-Cornell Medical Center/Memorial Sloan-Kettering Cancer Center, Dates: July, 1992-June, 1994

General Surgery Institution:
University of California, Los Angeles Dates: July, 1989-June, 1992 and July, 1984-June, 1986

Surgical Oncology Institution:
Surgery Branch, National Cancer Institute, National Institutes of Health Dates: July, 1986-June, 1989

Board Certification:
General Surgery: certificate number 38254; May 5, 1993
Cardiothoracic Surgery: certificate number 5615; June 2, 1995

Memberships:

  • Phi Beta Kappa Honor Society: since 1979
  • American Medical Association: since 1980
  • Alpha Omega Alpha Honorary Society: since 1982
  • American College of Surgeons Candidate Member: 1986-1994
  • American College of Surgeons Associate Member: since 1994
  • American Association of Immunologists: 1986-1992
  • New York Academy of Sciences: since 1987
  • American Association for the Advancement of Science: since 1987
  • American College of Cardiology: 1992-1996
  • New York Society for Thoracic Surgery: since 1993
  • Longmire Surgical Society: since 1993
  • New York Hospital-Cornell Cardiothoracic Surgical Society: since 1994
  • Society of Surgical Oncology: since 1995
  • San Francisco Surgical Society: since 1996
  • UCLA-Jonnson Comprehensive Cancer Center Thoracic Tumor Board (Chairman): 1997
  • UCSF-Mt Zion Cancer Center Thoracic Tumor Board (Chairman): 1994-1997
  • Cancer and Leukemia Group B (Investigator): 1995-1997
  • UCSF Thoracic Oncology Research Group: 1995-1997

Committees
Local/Regional
UCLA-Jonsson Comprehensive Cancer Center Quality Assurance Committee: 1997
UCLA-Cancer Committee: 1997
UCLA-Jonsson Comprehensive Cancer Center Committee: 1997

Preferred Oncology Network of California Lung Cancer Committee (Chairman): 1994-1995

UCSF Cancer Center Protocol Review Committee: 1995-1997

UCSF Cancer Center Steering Committee: 1995-1997

National/International
CALGB Surgery Committee: 1995-1997

CALGB Thoracic Surgery Subcommittee: 1995-1997

CALGB Respiratory Committee: 1995-1997

Research Topics
Specific cellular antigens in human lung cancer: UCSF School of Medicine and UCLA School of Medicine; 1994-present.

Role of interleukin-4 in lung cancer and mesothelioma: UCSF School of Medicine and UCLA School of Medicine; 1995-present.

Role of intraoperative radiation in human mesothelioma: UCSF School of Medicine and UCSF-Mt Zion Cancer Center; 1994-1997.

Dendritic cell-derived vaccines in human lung cancer: UCSF School of Medicine and UCLA School of Medicine; 1996-present.

Photodynamic therapy in lung cancer, mesothelioma and esophageal disease. UCLA School of Medicine and Jonnson Comprehensive Cancer Center; 1997-present.

Bibliography Abstracts
Jablons DM, Roach M, Jahan TM, and Cameron RB. Resection and intraoperative radiotherapy (IORT) followed by three-dimensional conformal radiotherapy +/- adjuvant chemotherapy for malignant mesothelioma. Proc 6th Int IORT Symposium, p. 37, 1996.

Rajasinghe H, Chen J, Merrick S, Keith F, Jablons DM, and Cameron RB. Postpneumonectomy pulmonary edema. Chest 110(4 suppl):80, 1996.

Jablons DM, Cameron RB, Xia W, Leland P, Varricchio F, and Puri R. In vitro and in vivo expression of IL-4 receptors on human malignant mesothelioma: implications for therapy. Proceedings of the American Association for Cancer Research 38:pending, 1997.

Jablons DM, Cameron RB, Xia W, Varricchio F, Lelan P, Kreitman R, Pastan I, Puri R. Detection of IL-4 Receptors on Human Mesotheliomas and Demonstration of Specific Cytotoxicity by a Recombinant IL-4 Pseudomonas Exotoxin Against Human Mesothelioma Cell Lines. Chest 112:115, 1997.

Papers
Cameron RB, Fringer J, Taylor C, Gilden R, and Figlin RA. Practice guidelines for non-small cell lung cancer. Cancer J 2(3A suppl):61-68, 1996.

Cameron RB, Smith NG, Taylor C, Gilden R, and Figlin RA. Practice guidelines for small cell lung cancer. Cancer J 2(3A suppl):69-75, 1996.

Jablons DM, Roach M, Jahan T, and Cameron RB. Resection and intraoperative radiotherapy (IORT) followed by three-dimensional conformal radiotherapy +/- adjuvant chemotherapy for malignant mesothelioma. Frontiers of Radiat Ther Oncol 31: (in press), 1996.

Other peer-reviewed publications
Cameron RB. Lung cancer: specifications for acceptable care. Preferred Health Systems, LLC, Bethesda, Maryland, 1996.

Book Chapters
1. Cameron RB and Ginsberg RJ. Surgery and neoadjuvant chemotherapy for non-small cell lung cancer. in Lung Cancer, Carney D, editor, Edward Arnold, Sevenoaks, Kent, England, 1995.

2. Hodder RV, Cameron RB, and Todd TRJ. Lung infections: Bacterial infections. in Thoracic Surgery, Pearson FG, Deslauriers J, Ginsberg RJ, et. al., editors. Churchill Livingstone, New York, 1995.

3. Cameron RB. Contributor. Surgery On Call, Gomella LG and Lefor AT, editors. Appleton & Lange, Norwalk, CT, 2nd edition, 1996.

4. Cameron RB and Jablons DM. Chest wall, pleura, mediastinum, and lung. in Current Surgical Diagnosis and Treatment. Way L, editor. Appleton & Lange, Norwalk, CT, 10

5. Cameron RB and Gonella JS. Classification Systems (TNM and Disease). in Clinician’s Pocket Reference, Gomella LG, editor, Appleton & Lange, Norwalk, CT, 8th edition, 1996.

6. Cameron RB. Bedside procedures. in Clinician’s Pocket Reference, Gomella LG, editor. Appleton & Lange, Norwalk, CT, 8th edition, 1996.

7. Robles R, Cameron RB, Roach M, and Cornett P. Lung Cancer. in Current Cancer Diagnosis and Treatment. Henderson IC and Northfelt D, editors. Appleton & Lange, Norwalk, CT, 1997 (in press).

Books
Cameron RB and Schwarz SL, editors. Laboratory Protocols for the Immunotherapy of Cancer. Surgery Branch, National Cancer Institute, Bethesda, MD, 1989.

Cameron RB, editor. Practical Oncology. Appleton & Lange, Norwalk, CT, 1994.

Reviews
Cameron RB. Book review of Atlas of video-assisted thoracic surgery by WT Brown. Surg Endo 9:, 1995.

Source: http://www.surgery.medsch.ucla.edu/asp/Doctors.asp?emp_name=Cameron,%20Robert%20B.%20M.D.

If you or a loved one has been diagnosed with an illness related to asbestos such as mesothelioma, speaking with a mesothelioma lawyer can help you understand if you have legal options for compensation.

Mesothelioma Lawsuit Evaluation

6976

By submitting this form I agree to the Terms of Use

Find a Doctor

Finding a mesothelioma doctor who is familiar with the disease and its treatment will help to ensure that you receive the best medical care possible. Contact a local specialist today.

Find a Doctor

Clinical Trials

Though there is currently no cure for mesothelioma, various clinical trials are underway to test new drugs and treatments in the fight against this disease. Search active clinical trials.

Find a Clinical Trial

Exposure Sites

Asbestos, the only known cause of mesothelioma cancer, was used for decades in jobsites throughout the country. Review a list of known asbestos exposure locations in your area.

Search Exposure Sites